APA (7th ed.) Citation

PH, C., SW, K., & JS, C. (2022). ASO Author Reflection: Primary Tumor Resection for Stage IV Lung Cancer after Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor. Annals of surgical oncology, 29(8), 4885. https://doi.org/10.1245/s10434-022-11487-3

Chicago Style (17th ed.) Citation

PH, Chen, Kuo SW, and Chen JS. "ASO Author Reflection: Primary Tumor Resection for Stage IV Lung Cancer After Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor." Annals of Surgical Oncology 29, no. 8 (2022): 4885. https://doi.org/10.1245/s10434-022-11487-3.

MLA (9th ed.) Citation

PH, Chen, et al. "ASO Author Reflection: Primary Tumor Resection for Stage IV Lung Cancer After Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor." Annals of Surgical Oncology, vol. 29, no. 8, 2022, p. 4885, https://doi.org/10.1245/s10434-022-11487-3.